Photocure ASA to Acquire Vesica Health Inc., Strengthening Leadership in Bladder Cancer Diagnostics

Impact · against what's priced in

Photocure ASA expands its bladder cancer diagnostics platform via the acquisition of Vesica Health, adding a high-sensitivity molecular test (AssureMDx) with FDA Breakthrough Designation. The integration of a noninvasive upstream diagnostic tool into Photocure's existing urology commercial infrastructure provides a clear path for revenue acceleration and market expansion into hematuria evaluation.

PHO+0.70

No priced-in read yet